Ovid Therapeutics, Inc. (OVID)

1.64 -0.01 (-0.61%) USD  |  NASDAQ  |  Dec 12, 16:00
1.64 0.00 (0.00%) After-Hours: 05:07
More

Ovid Therapeutics Research and Development Expense (Annual): 36.37M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
AnaptysBio, Inc. 163.23M
Ionis Pharmaceuticals, Inc. 901.53M
MannKind Corp. 45.89M
Cassava Sciences, Inc. 69.64M
Cidara Therapeutics, Inc. 71.88M